Skip to main content

4 Result(s)

within Paula Cramer Remove this filter Cancer Research Remove this filter

and

  1. Article

    Open Access

    Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial

    Julia von Tresckow, Paula Cramer, Sandra Robrecht, Petra Langerbeins… in Leukemia (2022)

    Download PDF (432 KB) View Article

  2. No Access

    Article

    Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy

    Moritz Fürstenau, Georg Hopfinger, Sandra Robrecht, Anna-Maria Fink… in Leukemia (2020)

  3. Article

    Open Access

    The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab

    Karl-Anton Kreuzer, Richard R. Furman, Stephan Stilgenbauer, Ronald L. Dubowy… in Leukemia (2020)

    Download PDF (652 KB) View Article

  4. No Access

    Article

    CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia

    Obinutuzumab (GA101) and ibrutinib show excellent efficacy for treatment of chronic lymphocytic leukemia (CLL). Preclinical investigations and a complementary safety profile were in support of testing their co...

    Julia von Tresckow, Paula Cramer, Jasmin Bahlo, Sandra Robrecht… in Leukemia (2019)